These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1397055

  • 1. Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis.
    Vrána O, Kiseleva VI, Poverenny AM, Brabec V.
    Eur J Pharmacol; 1992 May 12; 226(1):5-13. PubMed ID: 1397055
    [Abstract] [Full Text] [Related]

  • 2. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J, Novakova O, Farrell N, Brabec V.
    Biochemistry; 2003 Jan 28; 42(3):792-800. PubMed ID: 12534292
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
    Payet D, Gaucheron F, Sip M, Leng M.
    Nucleic Acids Res; 1993 Dec 25; 21(25):5846-51. PubMed ID: 8290343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J, Brabec V.
    Biochemistry; 1995 Sep 26; 34(38):12379-87. PubMed ID: 7547982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.
    Poirier MC, Lippard SJ, Zwelling LA, Ushay HM, Kerrigan D, Thill CC, Santella RM, Grunberger D, Yuspa SH.
    Proc Natl Acad Sci U S A; 1982 Nov 26; 79(21):6443-7. PubMed ID: 6959129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).
    Bellon SF, Coleman JH, Lippard SJ.
    Biochemistry; 1991 Aug 13; 30(32):8026-35. PubMed ID: 1868076
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reaction of nucleic acids with cis-diamminedichloroplatinum(II): interstrand cross-links.
    Rahmouni A, Leng M.
    Biochemistry; 1987 Nov 17; 26(23):7229-34. PubMed ID: 3427071
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.
    Terheggen PM, Floot BG, Lempers EL, van Tellingen O, Begg AC, den Engelse L.
    Cancer Chemother Pharmacol; 1991 Nov 17; 28(3):185-91. PubMed ID: 1855275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.